Haleon PLC Sponsored ADR (HLN)
(Delayed Data from NYSE)
$8.26 USD
-0.17 (-2.02%)
Updated Jun 28, 2024 04:00 PM ET
After-Market: $8.27 +0.01 (0.12%) 6:44 PM ET
3-Hold of 5 3
B Value B Growth C Momentum B VGM
Price, Consensus and EPS Surprise
HLN 8.26 -0.17(-2.02%)
Will HLN be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for HLN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for HLN
Dr. Reddy's (RDY) to Acquire Haleon's Nicotine Addiction Drug
GSK Outperforms Industry on Strength in Key Drugs & Vaccines
HLN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Pfizer (PFE) to Decrease Stake in Haleon From 32% to 24%
AHCO vs. HLN: Which Stock Should Value Investors Buy Now?
GSK Key Drugs & Vaccines Help Stock Outperform Industry YTD
Other News for HLN
Notable Two Hundred Day Moving Average Cross - HLN
LONDON MARKET CLOSE: CAC 40 underperforms amid political uncertainty
Dr. Reddy’s to Acquire Nicotinell and Related Portfolio in Significant Step Towards Building Global Consumer Healthcare Business
Haleon To Offload Non-Core Nicotine Therapy Business To Dr. Reddy's For Over $600M
Dr. Reddy's to acquire Haleon's global portfolio of brands in the NRT category